Spyre Therapeutics (SYRE) Tax Rate (2021 - 2025)
Spyre Therapeutics' (SYRE) quarterly Tax Rate came in at 0.03% in Q1 2025, up 11.0% YoY from 0.03% in Q1 2024, and up 1985.38% on a QoQ basis from 0.0% in Q4 2024.
Spyre Therapeutics (SYRE) Tax Rate (2021 - 2025) Analysis & Trends
Spyre Therapeutics (SYRE) has 5 years of Tax Rate data on file, last reported at 0.03% in Q1 2025.
- Quarterly Tax Rate rose 11.0% year-over-year to 0.03% in Q1 2025, while the trailing twelve-month figure through Dec 2025 was 0.01% (up 3.0% YoY) and the FY2025 annual result came in at 0.01%, up 3.0% from the prior year.
- Tax Rate rose to 0.03% in Q1 2025, from 0.0% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 1.13% in Q3 2022 to a low of 1.37% in Q2 2021.
- A 5-year average of 0.05% and a median of 0.03% in 2024 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2022 — Tax Rate soared 133 bps — and 2023, when it sank 114 bps.
- Tracing SYRE's Tax Rate over 5 years: stood at 0.11% in 2021, then sank by 80 bps to 0.2% in 2022, then surged by 96 bps to 0.01% in 2023, then jumped by 76 bps to 0.0% in 2024, then surged by 1985 bps to 0.03% in 2025.
- The last three Tax Rate figures came in at 0.03% (Q1 2025), 0.0% (Q4 2024), and 0.03% (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Spyre Therapeutics | 9.13 Bn | 9.13 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 0.03% |
| Mar 31, 2025 | 0.03% |
| Mar 31, 2025 | 0.03% |
| Dec 31, 2024 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | -0.03% |
| Sep 30, 2024 | -0.03% |
| Sep 30, 2024 | -0.03% |
| Mar 31, 2024 | -0.07% |
| Mar 31, 2024 | -0.07% |
| Mar 31, 2024 | -0.07% |
| Sep 30, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.20% |
| Mar 31, 2023 | 0.20% |